NasdaqGM - Delayed Quote USD

Phibro Animal Health Corporation (PAHC)

12.44 -0.12 (-0.96%)
At close: April 25 at 4:00 PM EDT
12.44 0.00 (0.00%)
After hours: April 25 at 4:20 PM EDT
Loading Chart for PAHC
DELL
  • Previous Close 12.56
  • Open 12.43
  • Bid 12.41 x 200
  • Ask 12.47 x 200
  • Day's Range 12.30 - 12.62
  • 52 Week Range 9.40 - 15.96
  • Volume 117,209
  • Avg. Volume 144,345
  • Market Cap (intraday) 503.865M
  • Beta (5Y Monthly) 0.74
  • PE Ratio (TTM) 33.62
  • EPS (TTM) 0.37
  • Earnings Date May 8, 2024
  • Forward Dividend & Yield 0.48 (3.86%)
  • Ex-Dividend Date Mar 5, 2024
  • 1y Target Est 10.75

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs. It also offers animal health products, such as antibacterials, anticoccidials, nutritional specialty, and vaccines and vaccine adjuvants for animal's health and performance, food safety, and animal welfare; and engages in development, manufacturing, and marketing of microbial and bioproducts for various applications serving animal health and nutrition, industrial, environmental, and agricultural customers. In addition, the company develops, manufactures, and markets conventionally licensed and autogenous vaccine products, as well as adjuvants for animal vaccine manufacturers. Further, it provides formulations and concentrations of trace minerals, such as zinc, manganese, copper, iron, and other compounds to fortify the daily feed requirements of their livestock's diets and maintain optimal balance of trace elements in animals. Additionally, the company offers specialty ingredients for personal care, industrial chemical, and chemical catalyst industries. It sells its animal health and mineral nutrition products through local sales offices to integrated poultry, swine, and cattle integrators, as well as through commercial animal feed manufacturers, wholesalers, and distributors. The company was formerly known as Philipp Brothers Chemicals, Inc. and changed its name to Phibro Animal Health Corporation in July 2003. Phibro Animal Health Corporation was founded in 1946 and is headquartered in Teaneck, New Jersey.

www.pahc.com

1,920

Full Time Employees

June 30

Fiscal Year Ends

Recent News: PAHC

Performance Overview: PAHC

Trailing total returns as of 4/25/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

PAHC
8.38%
S&P 500
5.84%

1-Year Return

PAHC
17.39%
S&P 500
22.03%

3-Year Return

PAHC
44.63%
S&P 500
20.77%

5-Year Return

PAHC
57.21%
S&P 500
72.46%

Compare To: PAHC

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: PAHC

Valuation Measures

Annual
As of 4/26/2024
  • Market Cap

    503.86M

  • Enterprise Value

    924.47M

  • Trailing P/E

    33.62

  • Forward P/E

    10.03

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.51

  • Price/Book (mrq)

    1.86

  • Enterprise Value/Revenue

    0.94

  • Enterprise Value/EBITDA

    11.05

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    1.51%

  • Return on Assets (ttm)

    3.72%

  • Return on Equity (ttm)

    5.49%

  • Revenue (ttm)

    982.01M

  • Net Income Avi to Common (ttm)

    14.8M

  • Diluted EPS (ttm)

    0.37

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    104.84M

  • Total Debt/Equity (mrq)

    189.47%

  • Levered Free Cash Flow (ttm)

    38.29M

Research Analysis: PAHC

Analyst Price Targets

9.00 Low
10.75 Average
12.44 Current
13.00
 

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Earnings

Consensus EPS
 

Company Insights: PAHC

Fair Value

12.44 Current
 

Dividend Score

0 Low
PAHC
Sector Avg.
100 High
 

Hiring Score

0 Low
PAHC
Sector Avg.
100 High
 

Insider Sentiment Score

0 Low
PAHC
Sector Avg.
100 High
 

Research Reports: PAHC

  • PAHC: What does Argus have to say about PAHC?

    PHIBRO ANIMAL HEALTH CORP-A has an Investment Rating of HOLD; a target price of $14.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Medium.

    Rating
    Price Target
     
  • PAHC: What does Argus have to say about PAHC?

    PHIBRO ANIMAL HEALTH CORP-A has an Investment Rating of HOLD; a target price of $14.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Medium.

    Rating
    Price Target
     
  • PAHC: Raising target price to $14.00

    PHIBRO ANIMAL HEALTH CORP-A has an Investment Rating of HOLD; a target price of $14.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Medium.

    Rating
    Price Target
     
  • PAHC: What does Argus have to say about PAHC?

    PHIBRO ANIMAL HEALTH CORP-A has an Investment Rating of HOLD; a target price of $13.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Medium.

    Rating
    Price Target
     

People Also Watch